Takeda’s Strengthens Pipeline with TiGenix and Denali Deals
By Jasmine Kalsi
Pharma Deals Review: Vol 2018 Issue 1 (Table of Contents)
Published: 27 Jan-2018
DOI: 10.3833/pdr.v2018.i1.2297 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Takeda has entered into deals with two biotechs, TiGenix and Denali Therapeutics, to bolster its pipeline in two of core therapy areas of focus - gastroenterology and central nervous system (CNS)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS